Comparison between 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography and positron emission tomography/computed tomography hardware fusion for staging of patients with lymphoma.

Allen-Auerbach, Martin; Quon, Andrew; Weber, Wolfgang A; Obrzut, Sebastian; Crawford, Tyler; Silverman, Daniel H S; Ratib, Osman; Phelps, Michael E; Czernin, Johannes

Allen-Auerbach, Martin; Quon, Andrew; Weber, Wolfgang A; Obrzut, Sebastian; Crawford, Tyler; Silverman, Daniel H S; Ratib, Osman; Phelps, Michael E; Czernin, Johannes.

Affiliation

Allen-Auerbach M; Department of Molecular and Medical Pharmacology, Ahmanson Biological Imaging Center, UCLA David Geffen School of Medicine at UCLA, Los Angeles, CA 90095-6942 USA.

Mol Imaging Biol ; 6(6): 411-6, 2004.

Article in En | MEDLINE | ID: mdl-15564152

Subject(s)

Fluorodeoxyglucose F18/analysis; Lymphoma/diagnostic imaging; Lymphoma/pathology; Female; Hodgkin Disease/diagnostic imaging; Hodgkin Disease/pathology; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Fluorodeoxyglucose F18 / Lymphoma Type of study: Diagnostic_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Mol Imaging Biol Journal subject: BIOLOGIA MOLECULAR / DIAGNOSTICO POR IMAGEM Year: 2004 Document type: Article Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links